Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2026 08:30 ET | Source: Dyadic International, Inc.

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
July 20, 2026 05:19 ET | Source: Research and Markets

Infectious Vaccine Collaboration and Licensing Deals Report 2016-2026 | The Definitive Benchmark for Infectious Vaccine Dealmaking

Dublin, July 20, 2026 (GLOBE NEWSWIRE) -- The "Infectious Vaccine Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a...
July 20, 2026 04:22 ET | Source: Research and Markets

Vaccine Collaboration and Licensing Deals 2016-2026 - Analyze 880+ Vaccine Partnerships and Benchmark Deals With Confidence

Dublin, July 20, 2026 (GLOBE NEWSWIRE) -- The "Vaccine Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
July 14, 2026 10:20 ET | Source: Research and Markets

Global Vaccine Sales Market to Reach US$141.40 Billion by 2036 as Next-Generation Platforms Accelerate Growth

Dublin, July 14, 2026 (GLOBE NEWSWIRE) -- The "Vaccine Sales Market Report 2026-2036" has been added to ResearchAndMarkets.com's offering.The global vaccine sales market is projected to grow from...
July 07, 2026 07:25 ET | Source: Dyadic International, Inc.

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expand Commercial Opportunity Dyadic’s Ebola preparedness work highlights C1’s potentia
June 19, 2026 22:57 ET | Source: ThinkCareBelieve

ThinkCareBelieve: Week 74 of the Trump Administration

Powerful Week 74 combined diplomacy and accountability with the signing of an historic MOU at the Palace of Versailles for U.S. Iran ceasefire for Peace.
June 08, 2026 11:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 08, 2026 09:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 08, 2026 08:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 08, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development